04/22/2024
12:06 PM | Legend Biotech (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
04/16/2024
6:29 AM | Legend Biotech (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
04/08/2024
6:03 AM | Legend Biotech (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
04/05/2024
11:18 AM | BlackRock Inc. (Filed by)
Legend Biotech (Subject)
| Form SC 13G/A | |
03/29/2024
7:00 AM | Legend Biotech (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
03/26/2024
4:22 PM | Ji Darren Xiaohui (Reporting)
Legend Biotech (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
03/25/2024
3:57 PM | Huang Ying (Reporting)
Legend Biotech (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
|
03/19/2024
10:09 AM | Legend Biotech (Subject)
Yau Wai Man Philip (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
03/19/2024
6:57 AM | Legend Biotech (Filer)
| Form F-3ASR | |
03/19/2024
6:02 AM | Legend Biotech (Filer)
| Form 20-F
Registration statement / Annual report / Transition report | |
03/15/2024
2:18 PM | Legend Biotech (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
03/13/2024
7:36 AM | Legend Biotech (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
03/11/2024
6:52 AM | Legend Biotech (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
02/28/2024
5:46 PM | Huang Ying (Reporting)
Legend Biotech (Subject)
| Form 144/A | |
02/28/2024
4:35 PM | Huang Ying (Reporting)
Legend Biotech (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
02/27/2024
6:47 PM | Huang Ying (Reporting)
Legend Biotech (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
02/23/2024
12:10 PM | Huang Ying (Reporting)
Legend Biotech (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
02/23/2024
6:16 AM | Legend Biotech (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
02/14/2024
7:34 PM | GenScript Biotech Corp (Filed by)
Legend Biotech (Subject)
| Form SC 13G/A | |
01/29/2024
4:25 PM | BlackRock Inc. (Filed by)
Legend Biotech (Subject)
| Form SC 13G | |
01/23/2024
8:00 AM | Legend Biotech (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
01/23/2024
6:30 AM | Legend Biotech (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
12/27/2023
9:00 AM | Legend Biotech (Subject)
Yau Wai Man Philip (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
12/22/2023
2:38 PM | Huang Ying (Reporting)
Legend Biotech (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
12/22/2023
2:21 PM | Legend Biotech (Subject)
Macomber Lori (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
12/21/2023
4:17 PM | Legend Biotech (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
12/12/2023
1:31 PM | Heyman Tomas J. (Reporting)
Legend Biotech (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
11/20/2023
5:02 AM | Legend Biotech (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
11/13/2023
7:30 AM | Legend Biotech (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
10/17/2023
4:39 PM | Huang Ying (Reporting)
Legend Biotech (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
10/17/2023
4:50 PM | Huang Ying (Reporting)
Legend Biotech (Subject)
| Form 144/A | |
10/17/2023
7:00 AM | Legend Biotech (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
10/16/2023
4:20 PM | Huang Ying (Reporting)
Legend Biotech (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
09/27/2023
11:02 AM | Huang Ying (Reporting)
Legend Biotech (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
09/25/2023
7:00 AM | Legend Biotech (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
09/22/2023
3:10 PM | Huang Ying (Reporting)
Legend Biotech (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
09/22/2023
3:20 PM | Legend Biotech (Subject)
Macomber Lori (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
09/18/2023
3:41 PM | Huang Ying (Reporting)
Legend Biotech (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
08/28/2023
9:00 AM | Legend Biotech (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
08/23/2023
3:27 PM | Legend Biotech (Subject)
Sanders Corazon D. (0001796536) (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
08/15/2023
5:10 AM | Legend Biotech (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
SHOCKING Crypto Leak… (Ad) A shocking leak has revealed tech giant Microsoft's plans to add crypto support to future products.
If the plans in these leaked internal documents pan out, we could see prices skyrocket for Bitcoin, Ethereum, XRP and MORE…
The coupling of gaming and cryptocurrency could absolutely transform digital finance as we know it in 2024.
 Claim your free seat by clicking here now. |
07/20/2023
7:00 AM | Legend Biotech (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
06/26/2023
9:30 AM | Legend Biotech (Subject)
Yau Wai Man Philip (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
06/07/2023
12:45 PM | Huang Ying (Reporting)
Legend Biotech (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
06/06/2023
3:44 PM | Legend Biotech (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
06/06/2023
2:00 PM | Huang Ying (Reporting)
Legend Biotech (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
06/05/2023
10:17 AM | Legend Biotech (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
06/01/2023
3:18 PM | Huang Ying (Reporting)
Legend Biotech (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
05/26/2023
8:01 AM | Legend Biotech (Filer)
| Form F-3ASR | |
05/25/2023
7:30 AM | Legend Biotech (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
05/18/2023
7:30 AM | Legend Biotech (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
05/16/2023
7:39 AM | Legend Biotech (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
05/10/2023
8:45 AM | FMR LLC (Filed by)
Legend Biotech (Subject)
| Form SC 13G/A | |
05/08/2023
7:45 AM | Legend Biotech (Filer)
| Form 424B5 | |
05/08/2023
7:46 AM | Legend Biotech (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
